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Abstract
Background: In this study we evaluated the usefulness of a free self-test for screening albuminuria
in the general population.
Methods: Dutch adults were invited by the Dutch Kidney Foundation to order a free albuminuria
self-test, consisting of three semi quantitative dipstick tests, via the Internet. Results were classified
in negative, low-positive and high-positive. In case of a positive test result, the tester was
recommended to visit a GP for supplementary examination and/or treatment. Participants of the
programme were sent a questionnaire for evaluation by e-mail eight weeks after receiving the self-
test.
Results: During the first 30 days of the self-test programme, 996,927 self-tests were ordered. In
total, 71,714 participants completed the questionnaire: 79% had a negative test result and 21% had
a positive test result (20% low-positive and 1% high-positive). Of the positive testers, 25% visited
a GP after testing for albuminuria. Among the 3,983 participants who visited a GP, 193 new diseases
were detected: 25 chronic renal failure, 152 hypertension and 31 diabetes mellitus.
Conclusion: Using a free self-test for screening albuminuria in the general population resulted in
a large response and a number of newly detected diseases. However, we found a very high
percentage of positive testers of which probably a large part is false positive. Furthermore, only a
small part of the positive testers visited a GP for additional examination and/or treatment. The
efficiency of such a campaign could be increased by embedding the testing in health care to reduce
the number of false-positive results and to ensure follow-up and treatment in case of a positive test
result.
Background
The prevalence rate of chronic diseases like cardiovascular
diseases and diabetes mellitus is rapidly increasing, partic-
ularly in industrialized countries [1,2]. The perceived
need for early detection of chronic diseases is growing to
prevent future problems for the patient and to reduce the
costs for health care. Therefore, screening for chronic dis-
orders in the general population becomes more popular.
In 2006, the Dutch Kidney Foundation started a program
to detect persons at risk for chronic renal failure (CRF) in
the Netherlands by offering a free self-test for albuminuria
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tion and can result in total loss of kidney function, neces-
sitating dialysis or kidney transplantation to prevent
death [3]. Dialysis and transplantation not only have a big
impact on patients, but also lead to high costs. In the
Netherlands, the annual health care costs of end-stage
CRF patients amount to more than 400 million euros [4].
CRF also increases the risk for cardiovascular morbidity
and mortality [5].
The early stages of CRF are asymptomatic. Since symp-
toms of CRF, like fatigue and weakness, only start when
the kidney function is decreased by about 60-70%, it is
difficult to detect the disease at an early stage [3]. The pres-
ence of an increased amount of protein in the urine (albu-
minuria) is an indicator for worsening kidney function
and increases the risk of developing CRF. Patients with
macroalbuminuria (albuminuria concentration > 200
mg/l) have a three times higher risk for dialysis or kidney
transplantation within 5 to 15 years [6]. When mac-
roalbuminuria is detected at an early stage of CRF, treat-
ment with an angiotensin-receptor blocker (ARB) or
angiotensin converting enzyme (ACE) inhibitor can pre-
vent or delay the development of end stage kidney disease
[7,8]. Due to the high impact of end-stage CRF for patients
and health care, the symptom-less early stages of the dis-
ease and the availability of preventive treatment, mass
screening for CRF can be justified according to the criteria
of Wilson and Jungner [9].
In the program, an albuminuria self-test was used as
screening tool. The popularity of self-tests is increasing.
Ryan et al. identified 104 self tests for 24 diseases, includ-
ing cancers, chronic diseases and infection, available on
the Internet according to a systematic Internet search [10].
People are increasingly interested in their health and with
a self-test an individual can obtain information without
the help of a health professional. Besides the benefit of
privacy, there are also disadvantages of the increasing
popularity of self-tests. The most important disadvantage
of self-tests is the number of false-positive test results and
its consequences in terms of unnecessary diagnostics,
unnecessary costs, medicalization and patient worries.
In the present study we evaluate the usefulness of a free
self-test for screening of albuminuria in the general popu-
lation. We investigated the following research questions:
1) what are the characteristics of the persons who ordered
a self-test for albuminuria?, 2) how many persons had a
positive test result on the albuminuria self-test?, 3) how
many persons visited a GP after testing positive for albu-
minuria?, and 4) how many persons with CRF and risk
factors for CRF (hypertension and diabetes mellitus) were
detected by the GP via the albuminuria self-test program?
Methods
Albuminuria self-test program
The Dutch Kidney Foundation started a screening pro-
gram for CRF in September 2006. With advertisements on
the radio, television, newspapers and the Internet, all
Dutch adults were invited to test for albuminuria with a
free self-test, called the 'Kidney check' (in Dutch 'Nier-
check'). The self-test could be ordered via the website of
the Dutch Kidney Foundation after registration of name,
address, age, gender and e-mail address, or by telephone.
Since a minority of the self-tests was ordered by tele-
phone, only data from the participants who ordered the
self-test via the Internet were used. The Internet order
form included a question about the willingness to com-
plete a questionnaire for evaluation of the self-test pro-
gram (informed consent). Notification for this
questionnaire was by e-mail. According to Dutch legisla-
tion, approval by a medical ethics committee was not
needed.
Self-test for albuminuria
The albuminuria self-test consisted of three semi quantita-
tive dipstick tests (Machery-Nagel: Düren, Germany)
accompanied with a manual and a colour chart to deter-
mine the test result. On three different days, with at least
five days in between, the first voided morning urine sam-
ple should be used for testing. In the manual it was
advised not to test during pregnancy or menstruation,
after heavy exercise or when suffering from influenza-like-
illness. After applying the dipstick test, the colour of the
stick indicated the level of albumin in the urine: 0, 30, 100
or 500 mg/l albumin respectively. To determine the test
result reliably, it was advised to read the test result in day-
light. Since a single dipstick test has a sensitivity of 96%
and a specificity of 85%, the total test result was consid-
ered positive (i.e. elevated albumin levels in the urine)
when in at least two out of three dipstick tests a concentra-
tion of 30 mg/l or higher was found. In case of a positive
test result, the tester was recommended to visit his/her GP
for additional examination and/or treatment. We classi-
fied the test results as negative, low-positive (at least two
positive dipstick tests; highest test result 30 mg/l) and
high-positive (at least two positive test results; at least one
test result of 100 mg/l or 500 mg/l).
Study population
All participants who gave permission, were sent a link for
a web-questionnaire by e-mail (personal URL for on-line
questionnaire) eight weeks after the self-test had been
sent. The questionnaire included questions about: 1)
demographic characteristics: age, gender, level of educa-
tion and postal code, 2) medical history: self-reported
presence of cardiovascular diseases, diabetes mellitus, kid-
ney disease, alcohol use, smoking history and body mass
index (BMI), 3) the results of the dipstick tests, and 4)Page 2 of 6
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tension, diabetes mellitus and/or a kidney disease.
Statistical analyses
Frequencies were calculated for the number of persons
with a negative, low-positive and high-positive test result
in the total group of participants, by age group (18-29
years, 30-39 years, 40-49 years, 50-59 years, 60-69 years
and 70 years and older) and for persons with or without
risk factors at baseline (diabetes mellitus and/or hyperten-
sion), respectively. Next, the number of patients who vis-
ited a GP after performing the self-test was calculated per
subgroup of the test result. Also, the number of detected
persons with CRF, hypertension and/or diabetes by the
GP was calculated per subgroup of the test result. Differ-
ences were tested with a Chi-square test. All analyses were
performed with SPSS 14.0.
Results
Characteristics of the respondents
The results are based on the tests ordered during the first
30 days of the screening program. In this period, 996,927
self-tests were ordered via the Internet (7.8% of the adult
population in the Netherlands). Persons who did not gave
permission to be approached (n = 257,532), participants
who did not complete the questionnaire (n = 639,238),
participants with an existing kidney disease (n = 7,031),
persons who did not use the test (n = 9,108) and persons
who did not remember the results of the three dipstick
tests (n = 12,304) were excluded from the analysis (see fig-
ure 1). The characteristics of the remaining respondents (n
= 71,714), the total group of testers (n = 996,927) and the
Dutch adult population are shown in table 1.
The mean age of the respondents was 53 years and 54%
was female. Compared with the total group of testers, the
respondents were older and more often female. The
higher mean age of the respondents was due to overrepre-
sentation of persons of 50-59 years and 60-69 years. Per-
sons who ordered a self-test were older compared with the
Dutch adult population. Relatively more tests were
ordered by persons of 40-49 years, 50-59 years and 60-69
years old. The mean BMI of the respondents was 25.5 kg/
m2, 32% was highly educated, 19% used medium to high
amounts of alcohol and 14% of the respondents was a
current smoker.
Self-reported results on the albuminuria self-test
Of the respondents, 56,885 (79.3%) reported a negative
test result, 14,065 respondents reported a low-positive
Table 1: Population characteristics
Respondents
(n = 71,714)
Total group of testers
(n = 996,927)
Dutch adult population in 2006*
Age categories
18-29 years (%) 4.6 12.2 18.4
30-39 years (%) 10.5 17.9 19.1
40-49 years (%) 19.3 23.3 19.9
50-59 years (%) 32.3 24.7 17.8
60-69 years (%) 25.8 15.5 12.0
70 years and older (%) 7.5 6.4 12.8
Gender (% female) 53.9 53.0 51.0
Education
No/Low 6.4 -- --
Medium 61.8 -- --
High 31.8 -- --
Alcohol use
No 53.0 -- --
Low 27.8 -- --
Medium 14.5 -- --
High 4.7 -- --
BMI (mean (SD)) 25.5 (3.8) -- --
Smoking
Current 13.7 -- --
Former 49.4 -- --
Never 36.9 -- --
Cardiovascular diseases
Hypertension (%) 19.3 -- --
Hypercholesterolaemia (%) 14.1 -- --
Previous myocardial infarction (%) 0.9 -- --
Diabetes Mellitus 5.7 -- --
* Source: Statistics Netherlands http://www.cbs.nlPage 3 of 6
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table 2 the percentage of participants with a positive test
result are shown by age group and for persons with or
without risk factors (diabetes mellitus and/or hyperten-
sion) at baseline. The percentage of respondents with a
positive result decreased with increasing age. The highest
proportion of high-positive testers was found in the age
group 18-29 years old (3%; p < 0.001 compared with the
other age groups) and the percentage of low-positive test-
ers was highest in the age group 30-39 years old (32%; p
< 0.001 compared with the age groups 40-49, 50-59, 60-
69 and 70+ years old). The proportion of high-positive
testers was highest in persons with diabetes mellitus
(1.3%), but the proportion differed not statistically signif-
icant with persons with hypertension and persons with-
out risk factors.
GP visits
The number of GP visits and the number of newly
detected diseases due to the screening program are shown
in table 3. Only participants with a positive test result
were recommended to visit a GP. Nevertheless, 0.5% of
the participants with a negative test result also visited the
GP and another 0.5% of them was planning to visit the GP
later. Of the positive testers, 25% visited a GP after testing
for albuminuria (25% and 33% of low-positive and high-
positive testers, respectively) and 31% of the positive test-
ers were planning to visit a GP at a later moment (31%
and 27% of low-positive and high-positive testers, respec-
tively).
In the group of 3,983 persons who visited a GP, 193 per-
sons with a new disease were detected: 25 newly detected
patients with a kidney disease, 152 newly detected hyper-
tension patients and 31 newly detected diabetes mellitus
patients. The percentage newly detected diseases was
higher among the persons with a high-positive test result
(10.4%) compared with the persons with a low-positive
(4.6%) and a negative test result (2.8%) (p < 0.001).
Flow chart of participantsigure 1
Flow chart of participants.
Persons who ordered a self-test: 
996,927 
No permission to approach: 257,532 
Questionnaires sent by email: 
739,395 
Wrong email address: 61,231 
Nonresponse: 578,007 
Completed questionnaires: 
100,157 
Test not used: 9,108 
Participants with a kidney disease: 7,031 
Did not remember test-results: 12,304 
Participants in statistical analyses: 
71,714 
 
Table 2: Number of respondents with albuminuria by age and for persons with and without risk factors (percentages).
Albuminuria, % (95% CI)
Low-positive High-positive Positive total
Age groups (years)
18-29 (n = 3,303) 29.7 (28.1 - 31.3) 3.0 (2.4 - 3.5) 32.7 (31.1 - 34.3)
30-39 (n = 7,513) 32.4 (31.4 - 33.5) 1.9 (1.6 - 2.2) 34.3 (33.3 - 35.4)
40-49 (n = 13,847) 27.0 (26.2 - 27.7) 1.7 (1.5 - 1.9) 28.7 (27.9 - 29.4)
50-59 (n = 23,160) 17.2 (16.7 - 17.7) 0.7 (0.6 - 0.8) 17.9 (17.4 - 18.4)
60-69 (n = 18,519) 12.2 (11.7 - 12.6) 0.5 (0.4 - 0.6) 12.7 (12.2 - 13.2)
70+ (n = 5,372) 12.5 (11.6 - 13.3) 0.7 (0.5 - 1.0) 13.2 (12.3 - 14.1)
Total (n = 71,714) 19.6 (19.3 - 19.9) 1.1 (1.0 - 1.1) 20.7 (20.4 - 21.0)
Presence of risk factors
No risk factors (n = 69,768) 19.6 (19.3 - 19.9) 1.1 (1.0 - 1.1) 20.7 (20.4 - 21.0)
Diabetes mellitus (n = 4,059) 18.9 (17.7 - 20.2) 1.3 (0.9 - 1.6) 20.2 (19.0 - 21.4)
Hypertension (n = 13,868) 18.1 (17.5 - 18.8) 1.1 (0.9 - 1.2) 19.2 (18.6 - 19.9)
Diabetes mellitus and hypertension (n = 1,946) 18.9 (17.2 - 20.7) 1.2 (0.7 - 1.7) 20.1 (18.3 - 21.9)Page 4 of 6
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During the first 30 days of the albuminuria screening pro-
gram, 996,927 self-tests were ordered via the Internet. Of
the testers who completed the questionnaire, 79%
reported a negative test result, 20% reported a low-posi-
tive test result and 1% of the participants reported a high-
positive test result. Of the positive testers, 25% visited a
GP after testing for albuminuria and 31% of the positive
testers were planning to visit a GP at a later moment. In
the group of 3,983 persons who consulted a GP after
applying the self-test, 193 persons with a newly detected
disease were found: 25 cases of a kidney disease, 152 cases
of hypertension and 31 cases of diabetes mellitus.
With the dipstick test used in this study it was possible to
discriminate between four albumin concentrations (0, 30,
100 or 500 mg/l), which makes it difficult to distinguish
between micro- and macroalbuminuria. Usually, micro-
albuminuria is defined as an urine albumin concentration
between 20-200 mg/l and macroalbuminuria is defined as
a concentration above 200 mg/l [11]. This suggests that
the group high-positive testers (> 100 mg/l) mainly
includes persons with macroalbuminuria. This is sup-
ported by the fact that the percentage of high-positive test-
ers in this study is comparable with the prevalence of
macroalbuminuria in population-based studies. For
example, Garg et al found a macroalbuminurie prevalence
of 1.3% in the U.S. population [12] and the PREVEND
study in the Netherlands found a prevalence of 0.6% in a
population-based cohort [13]. However, besides the high-
positive testers, we also found an extremely high percent-
age respondents with a low-positive test result. It is likely
that a part of the 20% low-positive test results are false
positive. This may be caused by applying the test or read-
ing the test results under the wrong conditions. Many peo-
ple may have read the dipstick result in artificial light
instead of day light, leading to misinterpretations. This
hypothesis was tested by investigating the relation
between the number of low-positive test results and dark-
ness in the early morning hours. The percentage of low-
positive testers appeared to be higher towards winter, as
the days shortened (results not shown).
A positive result of the program is the high number of self-
tests that were ordered. With one million tests ordered, we
can assume that the program increased awareness among
the Dutch population about the risk of renal diseases. Fur-
thermore, the program resulted not only in a number of
newly detected patients with a kidney disease, but also
patients with chronic conditions that increase the risk of
CRF were detected (diabetes mellitus and hypertension).
Also some negative aspects can be discerned. When a part
of the low-positive test results is false positive, this causes
worries among the test users, unnecessary use of health
care and therefore unnecessary costs. Moreover, the a-pri-
ori risk on CRF in the general population is low (similar
to the prevalence in the general population of about 1%).
In combination with the diagnostic value of the used dip-
stick tests, this will lead to only a small posterior risk on
the disease after a positive test result. Under these circum-
stances, it is better to test in populations at high risk, such
as patients with hypertension or diabetes mellitus. Finally,
75% of the positive testers had not consulted their general
practitioner in relation to this test result in the study
period, but some may have done that at a later stage. The
reasons for this apparent lack of adequate reactions to
unfavorable test results are unclear and call for further
investigation.
It is obvious that we found the lowest percentages of peo-
ple with a high-positive test result in the older age groups,
in spite of an increased prevalence of cardiovascular risk
factors and diabetes mellitus by age (data not shown),
which is not in line with age-specific macroalbuminuria
prevalence reported elsewhere [12]. This suggests that the
albuminuria self-test has been ordered by relatively
unhealthy young individuals and healthy older individu-
als. Older individuals with chronic diseases may already
Table 3: Number of reported newly detected diseases by a GP after the self-test program (n = 71,714)
Test result
Negative
(n = 56,885)
Low-positive
(n = 14,065)
High-positive
(n = 764)
Total
(n = 71,714)
GP visit?
Yes 288 (0.5%) 3,444 (24.5%) 251 (32.8%) 3,983 (5.6%)
Newly detected disease?
No 280 3,285 225 3,790
Yes 8 (2.8%) 159 (4.6%) 26 (10.4%) 193 (4.8%)
Which diseases?
Kidney disease 0 15 10 25
Hypertension 5 131 16 152
Diabetes Mellitus 3 25 3 31Page 5 of 6
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ple might be less familiar with Internet and/or have less
access to Internet. Therefore, using a self-testing via the
Internet for the detection of (chronic) disease could be a
good method for detecting young people at risk.
This study has some limitations. First, the results are based
on self-reported data from the participants of the screen-
ing program. It was not possible to validate the self-
reported diagnoses of kidney diseases, cardiovascular dis-
eases and diabetes mellitus and the results of the self-test.
Second, only 13.5% of the participants responded on the
questionnaire. It is unknown if the respondents are repre-
sentative for the total group of participants of the CRF pro-
gram. The motivation to complete the questionnaire may
have been larger in testers with positive test results. On the
other hand, the percentage high-positive testers was com-
parable with the prevalence of macroalbuminuria in other
studies in the general population [12,13], which makes
the occurrence of a selective response less likely.
The efficiency of such a campaign could be increased by
embedding the testing in health care, e.g. the GP practice,
to reduce the number of false-positive results and to
ensure follow-up and treatment in case of a positive test
result. The number of false-positive test results can be
reduced 1) by testing in a population with a higher a pri-
ori risk on albuminuria, such as patients with hyperten-
sion and/or diabetes mellitus, and 2) when testing is
performed by a health professional. The low number of
GP consultations reduce the efficiency of the program,
because positive testers who do not visit a GP, do not
receive the treatment needed to prevent future kidney dis-
ease.
Conclusion
It can be concluded that using a free self-test for screening
of albuminuria had a large impact in the general popula-
tion and resulted in a limited number of newly detected
diseases. However there was a large number of probably
false-positive test results and only a small part of the pos-
itive testers visited a GP for additional examination and/
or treatment. Therefore, the efficiency of such a campaign
could be increased by embedding the testing in health
care, e.g. the GP practice, to reduce the number of false-
positive results and to ensure follow-up and treatment in
case of a positive test result.
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